This month’s journal-based CME article is titled "Long-term Toxicity after Transarterial Radioembolization with Yttrium-90 using Resin Microspheres for Neuroendocrine Tumor Liver Matastases. This clinical study evaluates long-term effects of yttrium-90 (Y-90) transarterial radioembolization (TARE) for unresectable hepatic metastases of neuroendocrine tumors (NET).
This program is designed to meet the educational needs of interventional radiologists, oncologists, oncologic surgeons, nurses, techs, and trainees at all levels with special interests in NET.
To receive CME credit for this journal-based CME activity, participants must read the journal article and score 75% or better on the post test. Participants will have three opportunities to score 75% or better.
After participating in this journal-based CME activity, learners should be able to
State prognostic factors that affect survival in patients with NET.
List survival rates after TARE in patients with and without extrahepatic disease.
Describe the long-term impact of TARE on hepatic function and associated liver function tests.
JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA
Yuki Tomozawa, MD
Younes Jahangirl, MD
Priya Pathak, MD
Kenneth J Kolbeck, MD, PhD
Ryan Schenning, MD
John A. Kaufman, MD, FSIR
Khashayar Farsad, MD, PhD
Charles T. Dotter Department of Interventional Radiology, Oregon Health and Science University
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).
The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved May 1, 2018. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.